News Headlines Article

How Health Care Reform Impacts San Diego Biotechs
Voice of San Diego

As the dust settles from the recent passage of the health care overhaul legislation, most San Diego biotechs are celebrating. For the most part, they got what they wanted from a bill that will impact their ability to fundraise, develop and sell their drugs and medical devices. Local trade group Biocom spent the last year lobbying for tax credits and patent protections that ended up in the legislation. Their success means that small companies can get more research money and local biotechs can develop some drugs without worrying about early competition from generics.